WE-E-224C-02: Investigation of Simple IMRT Delivery to Stage I Lung Cancer Patients with Significant Respiratory Motion Using Respiratory Gated CT Scans

2006 ◽  
Vol 33 (6Part21) ◽  
pp. 2256-2256
Author(s):  
B Reitz ◽  
A Colonias ◽  
D Parda ◽  
M Miften
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Respiratory Motion ◽  
Stage I ◽  
Ct Scans ◽  
Lung Cancer Patients ◽  
Stage I Lung Cancer

scholarly journals Early death in Danish stage I lung cancer patients: a population-based case study

2018 ◽  
Vol 57 (11) ◽  
pp. 1561-1566 ◽  
Author(s):  
Niels Lyhne Christensen ◽  
Anne Mette Tranberg Kejs ◽  
Erik Jakobsen ◽  
Susanne Oksbjerg Dalton ◽  
Torben Riis Rasmussen
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Early Death ◽  
Population Based ◽  
Stage I ◽  
Lung Cancer Patients ◽  
Stage I Lung Cancer

scholarly journals The prognostic value of PET/CT in clinical stage I lung cancer patients: A propensity-match analysis.

2019 ◽  
Author(s):  
Bing-Yen Wang ◽  
Wei-Heng Hung ◽  
Jing-Yang Huang ◽  
Heng-Chung Chen ◽  
Ching-Hsiung Lin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Clinical Stage ◽  
Survival Rates ◽  
Small Cell ◽  
Stage I ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Pet Ct ◽  
Stage I Lung Cancer

Abstract Introduction The application of PET/CT directly improved treatment choice and management in 25% of non-small cell lung cancer patients and 29% of small cell lung cancer patients. However, the long-term outcome of altering the management of these patients remains unclear. The aim of this study was to compare the 5-year overall survival rates of two groups of clinical stage I lung cancer patients: those who received PET/CT and those who did not.Methods Data were obtained from the Taiwan Society of Cancer Registry. There were 6,587 clinical stage I lung cancer patients analyzed between 2009 and 2014 in this retrospective study. We performed propensity matching to reduce the bias; it resulted in both groups having 2,649 patients. We measured the 1, 3, and 5-year survival rates of all clinical stage I lung cancer patients and the survival rates of pathological I, II and III lung cancer patients and compared the survival rates between clinical stage I lung cancer patients with PET/CT scans and patients without PET/CT scans.Results The 1, 3, and 5-year survival rates of all clinical stage I lung cancer patients are 97.2%, 88.2% and 79.0%, respectively. The 1, 3, and 5-year survival rates are 97.0%, 88.2% and 79.8% in the PET/CT group and 97.5%, 88.1% and 78.2% in the no PET/CT group; there was no statistical difference (p= 0.6528).Conclusion Although stage I lung cancer patients who received PET/CT had their management strategies modified and avoided any unnecessary thoracotomies, our data showed that there was no 5-year survival benefit for these patients.

scholarly journals Prognostic value of cigarette smoking index for pathological stage I lung cancer patients

2004 ◽  
Vol 18 (2) ◽  
pp. 98-102 ◽  
Author(s):  
Kenjiro Fukuhara ◽  
Katsuhiro Nakagawa ◽  
Masahiro Sakaguchi ◽  
Teruo Iwasaki ◽  
Tsutomu Yasumitsu
Keyword(s):  
Lung Cancer ◽  
Cigarette Smoking ◽  
Cancer Patients ◽  
Prognostic Value ◽  
Stage I ◽  
Pathological Stage ◽  
Lung Cancer Patients ◽  
Stage I Lung Cancer ◽  
Smoking Index
Sign in / Sign up

Export Citation Format

Share Document